Cibinqo

Cibinqo (abrocitinib) is a prescription medication used to treat Atopic dermatitis (eczema). A once-daily pill for moderate-to-severe eczema that helps relieve itch and clear the skin.

Blocks the JAK1 enzyme involved in the immune signals that cause eczema inflammation and itch.

Commonly reported side effects of Cibinqo include Serious infections, Blood clots, Increased cancer risk, Nausea, and Headache. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Yes. Cibinqo carries an FDA Boxed Warning — the agency's most serious safety warning. Read the full prescribing information and talk to your doctor about the risks before starting or changing treatment.

The active ingredient in Cibinqo is abrocitinib, which belongs to a class of medicines known as JAK1 Inhibitor.

Cibinqo is manufactured by Pfizer. It was first approved in 2022.

You may be able to lower the cost of Cibinqo by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.